← Open Payments lookup

MARTIN FRAZEE: Open Payments

NPI 1548824089 · WOBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,019 in 163 payments from 18 companies in 2025. Trend: 2023 $321 · 2024 $3,667 · 2025 $4,019

Food & beverage: $3,975Education: $44
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$911
ABBVIE INC.17$466
Alkermes, Inc.15$377
Otsuka America Pharmaceutical, Inc.13$359
Lundbeck LLC11$332
Neurocrine BioSciences, Inc.11$273
Vanda Pharmaceuticals Inc.18$249
E.R. Squibb & Sons, L.L.C.7$166
Braeburn Inc.10$163
Takeda Pharmaceuticals U.S.A., Inc.8$140

Products named: CAPLYTA, REXULTI, VRAYLAR, INGREZZA, FANAPT, ARISTADA, COBENFY, BRIXADI.

Industry payments across MA — which companies pay providers there.